Susquehanna International Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $301M | Buy |
2,157,100
+651,000
| +43% | +$91.2M | 0.03% | 379 |
|
|
2025
Q4 | $185M | Sell |
1,506,100
-383,700
| -20% | -$46.6M | 0.02% | 564 |
|
|
2025
Q3 | $210M | Sell |
1,889,800
-364,300
| -16% | -$41.4M | 0.02% | 517 |
|
|
2025
Q2 | $250M | Buy |
2,254,100
+111,800
| +5% | +$11.9M | 0.03% | 394 |
|
|
2025
Q1 | $240M | Sell |
2,142,300
-193,000
| -8% | -$19.9M | 0.04% | 339 |
|
|
2024
Q4 | $216M | Sell |
2,335,300
-335,200
| -13% | -$30.2M | 0.03% | 403 |
|
|
2024
Q3 | $224M | Sell |
2,670,500
-1,136,700
| -30% | -$86.7M | 0.04% | 365 |
|
|
2024
Q2 | $261M | Buy |
3,807,200
+1,758,600
| +86% | +$117M | 0.05% | 280 |
|
|
2024
Q1 | $150M | Sell |
2,048,600
-252,900
| -11% | -$19.4M | 0.03% | 502 |
|
|
2023
Q4 | $186M | Buy |
2,301,500
+3,700
| +0.2% | +$288K | 0.04% | 422 |
|
|
2023
Q3 | $172M | Buy |
2,297,800
+297,100
| +15% | +$22.9M | 0.04% | 399 |
|
|
2023
Q2 | $154M | Sell |
2,000,700
-202,700
| -9% | -$16.2M | 0.03% | 431 |
|
|
2023
Q1 | $183M | Sell |
2,203,400
-961,000
| -30% | -$79.6M | 0.04% | 381 |
|
|
2022
Q4 | $272M | Buy |
3,164,400
+1,211,600
| +62% | +$95.9M | 0.07% | 250 |
|
|
2022
Q3 | $120M | Sell |
1,952,800
-558,000
| -22% | -$35.2M | 0.03% | 444 |
|
|
2022
Q2 | $155M | Sell |
2,510,800
-1,044,400
| -29% | -$64.7M | 0.04% | 374 |
|
|
2022
Q1 | $211M | Sell |
3,555,200
-2,037,600
| -36% | -$130M | 0.04% | 383 |
|
|
2021
Q4 | $406M | Buy |
5,592,800
+1,012,000
| +22% | +$69.7M | 0.06% | 257 |
|
|
2021
Q3 | $320M | Sell |
4,580,800
-1,914,900
| -29% | -$135M | 0.04% | 355 |
|
|
2021
Q2 | $447M | Sell |
6,495,700
-2,103,100
| -24% | -$140M | 0.06% | 247 |
|
|
2021
Q1 | $556M | Buy |
8,598,800
+4,310,700
| +101% | +$278M | 0.09% | 180 |
|
|
2020
Q4 | $250M | Sell |
4,288,100
-1,149,100
| -21% | -$69.3M | 0.04% | 359 |
|
|
2020
Q3 | $344M | Sell |
5,437,200
-250,800
| -4% | -$17.4M | 0.07% | 221 |
|
|
2020
Q2 | $438M | Sell |
5,688,000
-3,705,400
| -39% | -$284M | 0.11% | 152 |
|
|
2020
Q1 | $702M | Buy |
9,393,400
+5,058,000
| +117% | +$349M | 0.22% | 65 |
|
|
2019
Q4 | $282M | Buy |
4,335,400
+876,600
| +25% | +$57.1M | 0.08% | 197 |
|
|
2019
Q3 | $219M | Buy |
3,458,800
+700,300
| +25% | +$45.8M | 0.07% | 225 |
|
|
2019
Q2 | $186M | Sell |
2,758,500
-430,200
| -13% | -$28.3M | 0.07% | 238 |
|
|
2019
Q1 | $207M | Sell |
3,188,700
-542,300
| -15% | -$36M | 0.09% | 193 |
|
|
2018
Q4 | $233M | Sell |
3,731,000
-35,600
| -0.9% | -$2.49M | 0.09% | 179 |
|
|
2018
Q3 | $291M | Buy |
3,766,600
+415,000
| +12% | +$31.3M | 0.1% | 168 |
|
|
2018
Q2 | $237M | Sell |
3,351,600
-940,000
| -22% | -$66.4M | 0.08% | 204 |
|
|
2018
Q1 | $324M | Sell |
4,291,600
-1,448,500
| -25% | -$115M | 0.12% | 133 |
|
|
2017
Q4 | $411M | Sell |
5,740,100
-211,800
| -4% | -$16.1M | 0.15% | 104 |
|
|
2017
Q3 | $482M | Buy |
5,951,900
+1,889,400
| +47% | +$144M | 0.19% | 78 |
|
|
2017
Q2 | $288M | Buy |
4,062,500
+635,200
| +19% | +$42.3M | 0.13% | 131 |
|
|
2017
Q1 | $233M | Sell |
3,427,300
-2,427,500
| -41% | -$171M | 0.12% | 144 |
|
|
2016
Q4 | $419M | Buy |
5,854,800
+261,500
| +5% | +$19.4M | 0.21% | 71 |
|
|
2016
Q3 | $443M | Buy |
5,593,300
+344,500
| +7% | +$28M | 0.21% | 67 |
|
|
2016
Q2 | $438M | Sell |
5,248,800
-1,047,900
| -17% | -$93M | 0.23% | 65 |
|
|
2016
Q1 | $578M | Sell |
6,296,700
-1,639,700
| -21% | -$148M | 0.31% | 48 |
|
|
2015
Q4 | $803M | Buy |
7,936,400
+262,500
| +3% | +$27.3M | 0.37% | 36 |
|
|
2015
Q3 | $754M | Buy |
7,673,900
+1,115,900
| +17% | +$124M | 0.33% | 35 |
|
|
2015
Q2 | $768M | Sell |
6,558,000
-1,178,200
| -15% | -$129M | 0.33% | 30 |
|
|
2015
Q1 | $759M | Sell |
7,736,200
-4,422,000
| -36% | -$449M | 0.34% | 28 |
|
|
2014
Q4 | $1.15B | Buy |
12,158,200
+3,839,800
| +46% | +$397M | 0.45% | 23 |
|
|
2014
Q3 | $885M | Buy |
8,318,400
+3,992,700
| +92% | +$391M | 0.34% | 33 |
|
|
2014
Q2 | $359M | Sell |
4,325,700
-1,565,000
| -27% | -$122M | 0.15% | 86 |
|
|
2014
Q1 | $417M | Buy |
5,890,700
+2,501,800
| +74% | +$196M | 0.19% | 70 |
|
|
2013
Q4 | $255M | Buy |
3,388,900
+1,055,200
| +45% | +$73.5M | 0.12% | 119 |
|
|
2013
Q3 | $147M | Sell |
2,333,700
-424,200
| -15% | -$25.4M | 0.08% | 208 |
|
|
2013
Q2 | $141M | Buy |
+2,757,900
| New | +$144M | 0.08% | 188 |
|
Other funds holding GILD
VCM
VPM
Susquehanna International Group's GILD Position: Q1 2026 in Review
Susquehanna International Group increased its Gilead Sciences (GILD) stake by 76% in Q1 2026, buying an estimated $62.5M and bringing the position to 1,032,658 shares worth $144M. The position accounts for 0.02% of the portfolio, ranked #642.
Susquehanna International Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $762M in Q4 2014. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Susquehanna International Group held 1,032,658 shares of Gilead Sciences worth $144M as of Q1 2026.
- Susquehanna International Group bought 446,635 Gilead Sciences shares in Q1 2026, an estimated $62.5M.
- Gilead Sciences made up 0.02% of Susquehanna International Group's portfolio in Q1 2026, its #642 holding.
- Susquehanna International Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Susquehanna International Group's Gilead Sciences position peaked at $762M in Q4 2014.
- 2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.